Literature DB >> 17530298

Treating severe Henoch-Schönlein and IgA nephritis with plasmapheresis alone.

Mohan Shenoy1, Milos V Ognjanovic, Malcolm G Coulthard.   

Abstract

The aim of our study was to determine the outcome of children with severe Henoch-Schönlein nephritis (HSN) and immunoglobulin A (IgA) nephritis (IgAN) treated with early plasmapheresis alone. Children with acute renal impairment, heavy proteinuria or both and histology greater than grade 3 were treated with early plasmapheresis alone. Glomerular filtration rate (GFR) estimated from plasma creatinine (eGFR), urine albumin:creatinine ratio (UA/UC) and blood pressure 2 weeks after treatment and were measured at the last follow-up. Sixteen children (14 HSN, 2 IgAN) had a mean eGFR of 56 (17-136) ml/min per 1.73 m2 and UA/UC of 590 (12-1,379) mg/mmol. Fifteen were referred at presentation and one after 2 months, and all commenced plasmapheresis within 6 (2-13) days. All had at least nine exchanges of 90 ml/kg over 2 weeks. At 2 weeks, the eGFR had increased by 51 (95% CI 34-68; P=0.002), and the UA/UC fell by 457 (95% CI 241-673; P=0.0001). At last review after 4 (1-7.5) years, the late-referred child had required a renal transplant but the other 15 had normal eGFRs (98-142), did not require hypotensive medication, and had normal or minimally elevated UA/UC (maximum 42). Children with severe HSN and IgAN recover well if treated with plasmapheresis alone without the need for immunosuppressive therapy. A randomised trial is needed.

Entities:  

Mesh:

Year:  2007        PMID: 17530298     DOI: 10.1007/s00467-007-0498-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.651


  27 in total

1.  Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study.

Authors:  Yukihiko Kawasaki; Junzo Suzuki; Hitoshi Suzuki
Journal:  Nephrol Dial Transplant       Date:  2004-04       Impact factor: 5.992

2.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

3.  Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schönlein nephritis.

Authors:  Yukihiko Kawasaki; Junzo Suzuki; Ruriko Nozawa; Shigeo Suzuki; Hitoshi Suzuki
Journal:  Pediatrics       Date:  2003-04       Impact factor: 7.124

4.  Factors affecting histological regression of crescentic Henoch-Schönlein nephritis in children.

Authors:  Jae Il Shin; Jee Min Park; Ji Hong Kim; Jae Seung Lee; Hyeon Joo Jeong
Journal:  Pediatr Nephrol       Date:  2005-11-04       Impact factor: 3.714

5.  Plasma exchange in progressive primary IgA nephropathy.

Authors:  R Coppo; B Basolo; D Roccatello; O Giachino; D Lajolo; G Martina; C Rollino; A Amore; M Costa; G Piccoli
Journal:  Int J Artif Organs       Date:  1985-07       Impact factor: 1.595

6.  Can azathioprine and steroids alter the progression of severe Henoch-Schönlein nephritis in children?

Authors:  Jae Il Shin; Jee Min Park; Youn Ho Shin; Ji Hong Kim; Jae Seung Lee; Pyung Kil Kim; Hyeon Joo Jeong
Journal:  Pediatr Nephrol       Date:  2005-05-12       Impact factor: 3.714

7.  Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy.

Authors:  J Bergstein; J Leiser; S P Andreoli
Journal:  Clin Nephrol       Date:  1998-01       Impact factor: 0.975

8.  Cyclosporin A therapy for severe Henoch-Schönlein nephritis with nephrotic syndrome.

Authors:  Jae Il Shin; Jee Min Park; Youn Ho Shin; Ji Hong Kim; Pyung Kil Kim; Jae Seung Lee; Hyeon Joo Jeong
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

9.  Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura.

Authors:  R Coppo; G Mazzucco; L Cagnoli; A Lupo; F P Schena
Journal:  Nephrol Dial Transplant       Date:  1997-11       Impact factor: 5.992

10.  Anaphylactoid purpura: characteristics of 16 patients who progressed to renal failure.

Authors:  T E Bunchman; S M Mauer; R K Sibley; R L Vernier
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

View more
  24 in total

Review 1.  Treatment-based literature of Henoch-Schönlein purpura nephritis in childhood.

Authors:  Marco Zaffanello; Vassilios Fanos
Journal:  Pediatr Nephrol       Date:  2008-12-09       Impact factor: 3.714

2.  Successful treatment of gastrointestinal involvement in Henoch-Schönlein purpura with plasmapheresis.

Authors:  Banu Acar; F Inci Arikan; Bulent Alioglu; Nergis Oner; Yildiz Dallar
Journal:  Pediatr Nephrol       Date:  2008-06-11       Impact factor: 3.714

Review 3.  Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013.

Authors:  Caitlin E Carter; Nadine M Benador
Journal:  Pediatr Nephrol       Date:  2013-06-29       Impact factor: 3.714

4.  Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch-Schönlein purpura nephritis.

Authors:  Jean-Claude Davin; Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2013-07-09       Impact factor: 3.714

5.  Improved outcome of Henoch-Schonlein purpura nephritis by early intensive treatment.

Authors:  Fang Deng; Ling Lu; Qin Zhang; Bo Hu; Xun Xia
Journal:  Indian J Pediatr       Date:  2011-07-08       Impact factor: 1.967

6.  Treatment strategies for Henoch-Schönlein purpura nephritis by histological and clinical severity.

Authors:  Takeshi Ninchoji; Hiroshi Kaito; Kandai Nozu; Yuya Hashimura; Kyoko Kanda; Ichiro Kamioka; Yuko Shima; Kiyoshi Hamahira; Koichi Nakanishi; Ryojiro Tanaka; Norishige Yoshikawa; Kazumoto Iijima; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2011-01-04       Impact factor: 3.714

Review 7.  Henoch-Schönlein purpura nephritis in children: incidence, pathogenesis and management.

Authors:  Jun-Yi Chen; Jian-Hua Mao
Journal:  World J Pediatr       Date:  2014-12-29       Impact factor: 2.764

Review 8.  Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature.

Authors:  Roberta Fenoglio; Carla Naretto; Bruno Basolo; Giacomo Quattrocchio; Michela Ferro; Paola Mesiano; Giulietta Beltrame; Dario Roccatello
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 9.  Systemic vasculitis in childhood.

Authors:  Abraham Gedalia; Raquel Cuchacovich
Journal:  Curr Rheumatol Rep       Date:  2009-12       Impact factor: 4.592

Review 10.  Small vessel vasculitis.

Authors:  Paul Brogan; Despina Eleftheriou; Michael Dillon
Journal:  Pediatr Nephrol       Date:  2009-11-03       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.